Diabetes Research and Clinical Practice This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study
Herpes zoster (HZ), more commonly known as shingles, is a painful rash caused by reactivation of the varicella-zoster virus (VZV), the same virus that causes chickenpox. From the epidemiological point of view, it is estimated that up to one in three people in the US will develop shingles in their lifetime [1]. Most of these cases are self-limited and can be managed out patiently, but severe cases can lead to hospitalisation. More severe rashes, particularly those that affect the face or the eyes, may be accompanied by other symptoms such as fever, headache, and fatigue and require hospitalisation [2]. (Source: Diabetes Res...
Source: Diabetes Research and Clinical Practice - March 7, 2024 Category: Endocrinology Authors: Carlo B. Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Francesco Romeo, Giuseppe Costa, Roberto Gnavi Source Type: research

International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
Many individuals with intermediate hyperglycaemia (IH), including impaired fasting glycaemia (IFG) and impaired glucose tolerance (IGT), as presently defined, will progress to type 2 diabetes (T2D). There is confirmatory evidence that T2D can be prevented by lifestyle modification and/or medications, in people with IGT diagnosed by 2-h plasma glucose (PG) during a 75-gram oral glucose tolerance test (OGTT). Over the last 40  years, a wealth of epidemiological data has confirmed the superior value of 1-h plasma glucose (PG) over fasting PG (FPG), glycated haemoglobin (HbA1c) and 2-h PG in populations of different ethnicity...
Source: Diabetes Research and Clinical Practice - March 6, 2024 Category: Endocrinology Authors: Michael Bergman, Melania Manco, Ilhan Satman, Juliana Chan, Maria In ês Schmidt, Giorgio Sesti, Teresa Vanessa Fiorentino, Muhammad Abdul-Ghani, Ram Jagannathan, Pramod Kumar Thyparambil Aravindakshan, Rafael Gabriel, Viswanathan Mohan, Martin Buysschaer Source Type: research

Correlational analysis of PLIN1 with inflammation in diabetic foot ulcer wounds
The persistent presence of inflammation is a recognized pathogenic mechanisms of diabetic foot ulcers (DFUs). We aimed to investigate the expression of PLIN1 in tissues from DFU patients and assess its potential association with inflammation-induced damage. (Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 5, 2024 Category: Endocrinology Authors: Mengting Wang, Xiaoliang Cao, Yanxing Shang, Yasu Jiang, Peng Chen, Chengwei Duan, Dongmei Zhang, Ping Wang, Jianfeng Ji, Zhenhua Gong Source Type: research

The association between patterns of weight change, diabetes status and glycaemia among adults with overweight and obesity
Type 2 diabetes has become a major public health challenge, affecting 5.9% of the population worldwide in 2021 [1]. One of the leading risk factors for type 2 diabetes is obesity [2]. In 2019, 14.0% of adults aged 18 years and over had obesity worldwide [3] while the prevalence of obesity in England was much higher, with 28% of adults having obesity [4]. Studies have shown higher risks of diabetes in adults who are overweight or obese. Therefore, reducing obesity was a key strategy to prevent diabetes in the population at high risk. (Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 5, 2024 Category: Endocrinology Authors: Ruoyu Yin, Amy L. Ahern, Louise Lafortune, Simon J. Griffin, Jean M. Strelitz, Julia Mueller Source Type: research

Consistent glycaemic efficacy and safety of concomitant use of iGlarLixi and sodium-glucose co-transporter-2 inhibitor therapy for type 2 diabetes: A patient-level pooled analysis of three randomised clinical trials
Type 2 diabetes (T2D) is a complex, heterogeneous disease affecting a high proportion of people with a spectrum of comorbidities that may influence the optimal treatment pathway for each individual [1 –3]. Cardiovascular and renal comorbidities, alongside other factors such as disease duration and patient preference, affect both the setting of glycaemic targets and choice of specific glucose-lowering medications, as advised by current American Diabetes Association (ADA) clinical guidelines [4]. Achieving sustained glycaemic control can be challenging and often requires multiple concomitant medications for its maintenance...
Source: Diabetes Research and Clinical Practice - March 4, 2024 Category: Endocrinology Authors: Francesco Giorgino, Cristian Guja, Hasan Ayd ın, Felipe Lauand, Lydie Melas-Melt, Julio Rosenstock Source Type: research

Carbohydrate counting knowledge and ambulatory glucose profile in persons living with type 1 diabetes
ContextThe amount of consumed carbohydrates is the strongest factor influencing glucose levels during the four hours following a meal.Our aim was to evaluate the association between carbohydrate counting knowledge and continuous glucose monitoring (CGM) parameters in patients with type 1 diabetes (T1D) using different insulin regimens. (Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 2, 2024 Category: Endocrinology Authors: Sopio Tatulashvili, Bleuenn Dreves, Laurent Meyer, Emmanuel Cosson, Michael Joubert Source Type: research

Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study
Diabetes management was carried out almost exclusively via telemedicine during the covid-19 lockdowns and quickly became the standard of care worldwide [1,2]. It is estimated that this evolution might persist in the post-pandemic period [3]. The boom of telemedicine also reflects high number of recent articles reporting mostly outstanding results of distant follow-up of children with type 1 diabetes (T1D) during the pandemic [2,4]. Importantly, all these studies were designed as retrospective or surveys [1,5 –9], which limits the strength of their results that cannot lead to any definitive conclusions. (Source: Diabetes ...
Source: Diabetes Research and Clinical Practice - March 2, 2024 Category: Endocrinology Authors: Lukas Plachy, Vit Neuman, Katerina Velichova, Matvei G. Slavenko, Alzbeta Santova, Shenali Anne Amaratunga, Barbora Obermannova, Stanislava Kolouskova, Stepanka Pruhova, Zdenek Sumnik, Lenka Petruzelkova Source Type: research

IDF23-0025 Treatment of 355 early type I diabetes with a combination of multiple immune modulatory drugs
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: K. Pirkalani Tags: Best Posters Source Type: research

IDF23-0026 A Meta-analysis on Smartphone-Based Artificial Intelligence Systems in Detecting Diabetic Retinopathy
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: S.U. Hasan, M.A.R. Siddiqui Tags: Best Posters Source Type: research

IDF23-0032 Soluble receptor for advanced glycation end products and CVD risk in T1D individuals with resistant hypertension
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: K. Adeshara, R. Lithovius, S. Mutter, V. Harjutsalo, M. Lehto, P.H. Groop Tags: Best Posters Source Type: research

IDF23-0033 Association of Diabetes with COVID-19 Mortality: A Systematic Review and Meta-Analysis of 118 Observational Studies
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: C. Li, N. Islam, J.P. Guti érrez, S.E. Gutiérrez-Barreto, A.C. Prado, R.L. Moolenaar, B. Lacey, P. Richter Tags: Best Posters Source Type: research

IDF23-0064 Associations of CR1 with mild cognitive impairment in type 2 diabetes mellitus
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: X. Zhou, S. Wang Tags: Best Posters Source Type: research

IDF23-0068 Digital Delivery of T2D Remission Program: Clinically Significant Weight Loss and Improved Glycemic Control
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: D.H. Laursen, S. Bendsen, E. Heath, C. Brandt Tags: Best Posters Source Type: research

IDF23-0079 Cardiorenal Events in Medication-Initiator Cohorts of Patients with Chronic Kidney Disease and Type 2 Diabetes in Japan
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: N. Kashihara, H. Kanegae, S. Okami, N.G. Oberprieler, M. Pladevall-Vila, J.B. Layton, S. Yamashita, C. Johannes, A. Farjat, C.P. Kovesdy, D. Vizcaya, Y. Yano Tags: Best Posters Source Type: research

IDF23-0082 Mild cognitive impairment in elderly patients with diabetes: effects of changes on BMI and appetite
(Source: Diabetes Research and Clinical Practice)
Source: Diabetes Research and Clinical Practice - March 1, 2024 Category: Endocrinology Authors: J. Li Tags: Best Posters Source Type: research